Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.
暂无分享，去创建一个
E. Schiff | Z. Goodman | R. D. de Man | I. Grimm | J. Dienstag | P. Husa | R. Perrillo | S. Karayalçın | Lynn D. Condreay | L. Crowther | M. Woessner | P. McPhillips | N. Brown | S. Karayalcin